Sientra, a medical aesthetics company, and Nanostring Technologies, a Washington-based provider of life science tools for research in genomics and proteomics, each obtained confirmation of their chapter 11 plans. In both cases, the chapter 11 plans will distribute sale proceeds to creditors.
S&C is representing the secured lenders in each transaction.
The S&C team advising on the Sientra transaction includes Ari Blaut, Benjamin Beller and Dave Rosenthal. John Anselmi and Michelle Thiry advised on financing matters. Brian Hamilton and Spencer Nord are advising on M&A matters. Jeff Hochberg and Eli Dubin advised on tax matters.
The S&C team advising on the Nanostring transaction includes Ari Blaut, Benjamin Beller, Justin DeCamp, Meng Yu, Matt Souza, Joey Tsang and Sam Ellis. Dustin Guzior is advising on litigation matters.